Vaira Leimane
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Surgery top 5%
- Molecular Biology
- Economics and Econometrics top 10%
- Co-authors
- Vija RiekstiņaTimothy H. HoltzCharles D. WellsKayla F. LasersonLorna E. ThorpeĢirts ŠķendersJ. Peter CegielskiCarole D. Mitnick
- Topics
- Tuberculosis Research and Epidemiology (29 papers)Pneumonia and Respiratory Infections (12 papers)Mycobacterium research and diagnosis (10 papers)
- Partner nations
- United StatesLatviaEstonia
In The Last Decade
Vaira Leimane
29 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 2.2k
- Epidemiology 1.8k
- Surgery 886
- Molecular Biology 227
- Economics and Econometrics 92
Countries citing papers authored by Vaira Leimane
This map shows the geographic impact of Vaira Leimane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaira Leimane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaira Leimane more than expected).
Fields of papers citing papers by Vaira Leimane
This network shows the impact of papers produced by Vaira Leimane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaira Leimane. The network helps show where Vaira Leimane may publish in the future.
Co-authorship network of co-authors of Vaira Leimane
This figure shows the co-authorship network connecting the top 25 collaborators of Vaira Leimane. A scholar is included among the top collaborators of Vaira Leimane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaira Leimane. Vaira Leimane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquilinebreakdown → | 505 |
| 3 | 6 | |
| 4 | 163 | |
| 5 | 233 | |
| 6 | 65 | |
| 7 | 115 | |
| 8 | 11 | |
| 9 | 64 | |
| 10 | 76 | |
| 11 | Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004. | 79 |
| 12 | 38 | |
| 13 | 4 | |
| 14 | 4 | |
| 15 | 134 | |
| 16 | 18 | |
| 17 | 216 | |
| 18 | 27 | |
| 19 | Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. | 147 |
| 20 | Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. | 20 |
About Vaira Leimane
Vaira Leimane is a scholar working on Infectious Diseases, Epidemiology and Surgery, having authored 30 papers that have together received 2.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (29 papers), Pneumonia and Respiratory Infections (12 papers) and Mycobacterium research and diagnosis (10 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Epidemiology (1.8k citations) and Surgery (886 citations). Vaira Leimane has collaborated with scholars based in United States, Latvia and Estonia. Frequent co-authors include Vija Riekstiņa, Timothy H. Holtz, Charles D. Wells, Kayla F. Laserson, Lorna E. Thorpe, Ģirts Šķenders, J. Peter Cegielski, Carole D. Mitnick, Martin P. Grobusch and Eduardo Gotuzzo. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.